Nusinersen in type 1 spinal muscular atrophy: Twelve‐month real‐world data
2019 · Annals of Neurology · 120 citations
https://doi.org/10.1002/ana.25533
M
Marco Piastra
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
253
Papers
4.5K
Citations
40
h-index
105
i10-index
Marco Piastra is an academic researcher from Università Cattolica del Sacro Cuore. The author has contributed to research in topics: Respiratory Support and Mechanisms & Neonatal Respiratory Health Research & Cardiac Arrest and Resuscitation. The author has an h-index of 40, co-authored 216 publications.
ORCID: 0000-0002-3144-8970Papers by this author
worksType I SMA “new natural history”: long‐term data in nusinersen‐treated patients
2021 · Annals of Clinical and Translational Neurology · 62 citations
https://doi.org/10.1002/acn3.51276
Dexmedetomidine is effective and safe during NIV in infants and young children with acute respiratory failure
2018 · BMC Pediatrics · 59 citations
https://doi.org/10.1186/s12887-018-1256-y
Preemptive analgesia with tramadol and fentanyl in pediatric neurosurgery
2000 · Child s Nervous System · 46 citations
https://doi.org/10.1007/s003810050019
Safety and Efficacy of Remifentanil in Craniosynostosis Repair in Children Less than 1 Year Old
2000 · Pediatric Neurosurgery · 43 citations
https://doi.org/10.1159/000028981
Onasemnogene abeparvovec in spinal muscular atrophy: predictors of efficacy and safety in naïve patients with spinal muscular atrophy and following switch from other therapies
2023 · EClinicalMedicine · 39 citations
https://doi.org/10.1016/j.eclinm.2023.101997
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat